13F-HR filed by Saturn V Capital Management LP
Saturn V Capital Management LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 26 holding rows worth $264,639,619.
- Accession
- 0001964437-24-000007
- Filer
- CIK 1964437
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 26 entries on the cover page, a total value of $264,639,619 stated on the cover page (in dollars after the unit check, H1), rows summing to $264,639,619 with VALUE read as dollars as filed, 13F file number 028-22863. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 64,196 | $27,606,848 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 503,089 | $22,674,221 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 479,681 | $21,484,912 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 215,680 | $16,285,997 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 113,224 | $15,441,489 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 272,036 | $14,738,910 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 178,589 | $14,703,232 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,673,919 | $14,111,137 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 856,849 | $14,069,461 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,128,478 | $13,293,471 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 760,941 | $12,464,214 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 164,773 | $9,749,618 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 419,654 | $8,615,497 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 627,760 | $8,298,987 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 1,113,824 | $7,262,132 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 713,536 | $7,078,277 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 249,609 | $6,255,202 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 593,306 | $6,111,052 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 367,429 | $5,452,646 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 1,140,310 | $5,085,783 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 390,084 | $3,834,526 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 152,178 | $3,556,400 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 71,442 | $1,931,077 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 70,000 | $1,628,200 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 47,660 | $1,623,776 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 72,831 | $1,282,554 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001964437-24-000007 | this filing | 2024-08-14 | acceptance time not in the bulk data set |